Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ), a lipid signalling enigma.

Authors:
Maria-Luisa Giudici Jonathan H Clarke Robin F Irvine

Adv Biol Regul 2016 05 2;61:47-50. Epub 2015 Dec 2.

Department of Pharmacology, Tennis Court Road, Cambridge CB2 1PD, UK. Electronic address:

The phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are an important family of enzymes, whose physiological roles are being teased out by a variety of means. Phosphatidylinositol-5-phosphate 4-kinase γ (PI5P4Kγ) is especially intriguing as its in vitro activity is very low. Here we review what is known about this enzyme and discuss some recent advances towards an understanding of its physiology. Additionally, the effects of the ATP-competitive inhibitor I-OMe Tyrphostin AG-538 on all three mammalian PI5P4Ks was explored, including two PI5P4Kγ mutants with altered ATP- or PI5P-binding sites. The results suggest a strategy for targeting non-ATP binding sites on inositol lipid kinases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbior.2015.11.007DOI Listing
May 2016

Publication Analysis

Top Keywords

4-kinase pi5p4kγ
8
phosphatidylinositol 5-phosphate
8
inhibitor i-ome
4
effects atp-competitive
4
i-ome tyrphostin
4
atp-competitive inhibitor
4
tyrphostin ag-538
4
three mammalian
4
ag-538 three
4
additionally effects
4
understanding physiology
4
low review
4
activity low
4
in vitro activity
4
review enzyme
4
enzyme discuss
4
mammalian pi5p4ks
4
discuss advances
4
physiology additionally
4
explored including
4

Similar Publications

Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities.

Authors:
Lauren B Arendse Susan Wyllie Kelly Chibale Ian H Gilbert

ACS Infect Dis 2021 Feb 16. Epub 2021 Feb 16.

Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee DD1 5EH, United Kingdom.

Protein and phosphoinositide kinases have been successfully exploited as drug targets in various disease areas, principally in oncology. In malaria, several protein kinases are under investigation as potential drug targets, and an inhibitor of phosphatidylinositol 4-kinase type III beta (PI4KIIIβ) is currently in phase 2 clinical studies. In this Perspective, we review the potential of kinases as drug targets for the treatment of malaria. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

The retromer is co-opted to deliver lipid enzymes for the biogenesis of lipid-enriched tombusviral replication organelles.

Authors:
Zhike Feng Jun-Ichi Inaba Peter D Nagy

Proc Natl Acad Sci U S A 2021 Jan;118(1)

Department of Plant Pathology, University of Kentucky, Lexington, KY 40546

Biogenesis of viral replication organelles (VROs) is critical for replication of positive-strand RNA viruses. In this work, we demonstrate that tomato bushy stunt virus (TBSV) and the closely related carnation Italian ringspot virus (CIRV) hijack the retromer to facilitate building VROs in the surrogate host yeast and in plants. Depletion of retromer proteins, which are needed for biogenesis of endosomal tubular transport carriers, strongly inhibits the peroxisome-associated TBSV and the mitochondria-associated CIRV replication in yeast and In vitro reconstitution revealed the need for the retromer for the full activity of the viral replicase. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Phosphatidylinositol 4-kinase β mutations cause nonsyndromic sensorineural deafness and inner ear malformation.

Authors:
Xiulan Su Yufei Feng Sofia A Rahman Shuilong Wu Guoan Li Franz Rüschendorf Lei Zhao Hongwei Cui Junqing Liang Liang Fang Hao Hu Sebastian Froehler Yong Yu Giannino Patone Oliver Hummel Qinghua Chen Klemens Raile Friedrich C Luft Sylvia Bähring Khalid Hussain Wei Chen Jingjing Zhang Maolian Gong

J Genet Genomics 2020 Oct 28;47(10):618-626. Epub 2020 Oct 28.

Experimental and Clinical Research Center (ECRC), A Joint Cooperation Between the Charité Medical Faculty and the Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Lindenberger Weg.80, Berlin, 13125, Germany. Electronic address:

Congenital hearing loss is a common disorder worldwide. Heterogeneous gene variation accounts for approximately 20-25% of such patients. We investigated a five-generation Chinese family with autosomal-dominant nonsyndromic sensorineural hearing loss (SNHL). Read More

View Article and Full-Text PDF
October 2020
Similar Publications

New Amidated 3,6-Diphenylated Imidazopyridazines with Potent Antiplasmodium Activity Are Dual Inhibitors of Phosphatidylinositol-4-kinase and cGMP-Dependent Protein Kinase.

Authors:
Peter Mubanga Cheuka Luyanda Centani Lauren B Arendse Stephen Fienberg Lynn Wambua Shoneeze S Renga Godwin Akpeko Dziwornu Malkeet Kumar Nina Lawrence Dale Taylor Sergio Wittlin Dina Coertzen Janette Reader Mariette van der Watt Lyn-Marie Birkholtz Kelly Chibale

ACS Infect Dis 2021 01 15;7(1):34-46. Epub 2020 Dec 15.

Department of Chemistry, University of Cape Town, Rondebosch, Cape Town 7701, South Africa.

Recent studies on 3,6-diphenylated imidazopyridazines have demonstrated impressive activity and efficacy in mouse models of malaria infection. Herein, we report the synthesis and antiplasmodium evaluation of a new series of amidated analogues and demonstrate that these compounds potently inhibit phosphatidylinositol-4-kinase (PI4K) type IIIβ while moderately inhibiting cyclic guanidine monophosphate (cGMP)-dependent protein kinase (PKG) activity . Using docking, we predict key binding interactions for these analogues within the adenosine triphosphate (ATP)-binding site of PI4K and PKG, paving the way for structure-based optimization of imidazopyridazines targeting both PI4K and PKG. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Genetic Analysis and Molecular Mapping of the Quantitative Trait Loci Governing Low Phytic Acid Content in a Novel LPA Rice Mutant, PLM11.

Authors:
Prem Chand Gyani Haritha Bollinedi Subbaiyan Gopala Krishnan Kunnummal Kurungara Vinod Archana Sachdeva Prolay Kumar Bhowmick Ranjith Kumar Ellur Mariappan Nagarajan Ashok Kumar Singh

Plants (Basel) 2020 Dec 8;9(12). Epub 2020 Dec 8.

Division of Genetics, ICAR-Indian Agricultural Research Institute, New Delhi 110012, India.

Breeding rice varieties with a low phytic acid (LPA) content is an effective strategy to overcome micronutrient deficiency in a population which consume rice as a staple food. An LPA mutant, Pusa LPA Mutant 11 (PLM11), was identified from an ethyl methane sulfonate (EMS)-induced population of Nagina 22. The present study was carried out to map the loci governing the LPA trait in PLM11 using an F population derived from a cross between a high phytic acid rice variety, Pusa Basmati 6, with PLM11. Read More

View Article and Full-Text PDF
December 2020
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap